piperacillin has been researched along with Acute Bacterial Prostatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattoir, V; Dargère, S; Daurel, C; de La Blanchardière, A; Guérin, F; Saint-Lorant, G; Verdon, R | 1 |
| Ikawa, K; Kajikawa, K; Kanao, K; Kato, Y; Kobayashi, I; Mitsui, K; Morikawa, N; Nakamura, K; Narushima, M; Nishikawa, G; Sumitomo, M; Tobiume, M; Watanabe, M; Yamada, Y; Yoshizawa, T; Zennami, K | 1 |
2 other study(ies) available for piperacillin and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catheter-Related Infections; Ceftazidime; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitalization; Hospitals, University; Humans; Immunocompromised Host; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prostatitis; Recurrence; Retrospective Studies; Risk Factors; Urinary Tract Infections; Young Adult | 2015 |
Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Area Under Curve; Escherichia coli; Humans; Infusions, Intravenous; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prostate; Prostatic Hyperplasia; Prostatitis; Proteus; Pseudomonas aeruginosa; Transurethral Resection of Prostate | 2015 |